Letter to the EMA Urging a Ban of Hydroxyethyl Starch Solutions in Europe
Read letter to EMA urging a ban on HES solutions in Europe.
Response from EMA Executive Director Dr. Guido Rasi, March 9, 2017
Read petition to FDA to ban HES solutions in the U.S.
Read letter from international experts supporting petition to FDA to ban HES solutions in the U.S.
July 25, 2017, interim response letter from the FDA.
Public Citizen and two leading medical experts sent a letter to the European Medicines Agency (EMA), urging the agency to ban hydroxyethyl starch (HES) solutions from the European market because the solutions cause kidney failure, bleeding, and death and there are safer alternatives available. Public Citizen and the two experts also sent the agency a copy of a petition submitted on the same day to the Food and Drug Administration (FDA) that asked the FDA to remove HES solutions from the U.S. market.
See Public Citizen’s other work on HES solutions.